U.S. Water Utilities Stock News

Pool Corporation recently announced that, effective May 4, 2026, John B. Watwood became President and CEO, succeeding Peter D. Arvan, while long-time director John E. Stokely moved into the Executive Chair role and the Board approved a quarterly dividend increase to US$1.30 per share. These leadership changes, alongside the appointment of new director Mark A. Pompa and a higher dividend, signal the Board’s focus on continuity, governance refreshment, and capital returns to...

In early May 2026, Southeastern Asset Management, which owns over 4% of Mattel, publicly urged the company to explore a sale or merger, arguing the market undervalues its brands and questioning its 2026 investment strategy. This activism comes shortly after Mattel reported higher first-quarter sales of US$862.2 million and a swing to US$61 million in net income, alongside ongoing share repurchases. Next, we’ll examine how this shareholder pressure to consider a sale shapes Mattel’s...

VEON’s recent Annual General Meeting saw shareholders re-elect all seven directors, while the company reported US$4.40 billion in 2025 revenue, 9.9% year-over-year growth, and US$759 million in digital revenues, alongside confirming a capital allocation policy targeting at least US$100 million in annual shareholder returns via buybacks. This combination of double-digit EBITDA growth, rapid expansion in digital services, and a clear shareholder return framework underscores management’s...

AI in healthcare sits at the crossroads of powerful themes investors are already watching, from inflation and tighter financing conditions to pressure on productivity and public budgets. As energy costs and rates keep policy makers on alert, hospitals, insurers and drug developers are under pressure to do more with less, while patients still want faster, more accurate care. The Transformative AI Healthcare Stocks screener filters for companies using AI to tackle diagnostics, treatment and...

Atlanta Braves Holdings, Inc. has reported past first-quarter 2026 results showing revenue of US$72.01 million versus US$47.21 million a year earlier, with a net loss of US$40.48 million and basic and diluted loss per share of US$0.63. The combination of higher revenue and a slightly narrower loss highlights how the Braves’ media and stadium-driven business model can add scale even while the team remains loss-making. We’ll now examine how this stronger year-over-year revenue performance...

NetScout Systems reported past fourth-quarter fiscal 2026 revenue of US$203.04 million and net income of US$18.24 million, with full-year revenue of US$859.48 million and a return to profitability at US$95.53 million. The company also issued fiscal 2027 guidance, targeting revenue between US$885.0 million and US$915.0 million and higher GAAP diluted EPS, supported by its acquisition of DigiCert’s DDoS protection business and growth in cybersecurity and service assurance. Next, we’ll examine...

Markets are wrestling with higher inflation, rising bond yields and volatile energy prices, so quality balance sheets matter more than ever. When borrowing costs and policy expectations shift frequently, companies with strong return on equity, resilient past performance and solid finances can give you cleaner exposure to long term growth stories, without relying on heavy leverage or speculative turnarounds. This article focuses on a curated screener that looks exactly for that mix of quality...

XPO, Inc. has already reported its first-quarter 2026 results, with sales of US$2,096 million and net income of US$101 million, alongside completing a US$155 million buyback of 1,114,779 shares announced in March 2025. The combination of stronger earnings, technology-driven efficiency gains in its less-than-truckload operations, and easing fuel costs underlines how XPO is using both operational execution and capital returns to strengthen its freight transportation business. We’ll now examine...

STAAR Surgical (STAA) is back in focus as Wall Street watches for a first quarter earnings update. The report is expected to show sequential improvement and a move from loss to profit, which is sharpening attention on profitability trends. See our latest analysis for STAAR Surgical. Recent trading has been choppy, with the share price down about 2% over the past week but still showing a 54.28% 90 day share price return and a 31.67% 1 year total shareholder return. These figures indicate that...

In the first quarter of 2026, Ingredion reported lower results year on year, with net sales of US$1,792 million and net income of US$142 million, and cut its full-year 2026 earnings guidance while flagging plant disruptions and the planned closure of its Cabo, Brazil facility. Alongside weaker earnings, the company signaled a shift in its footprint and capital allocation by consolidating Latin American operations and continuing share buybacks, repurchasing 674,911 shares for US$78.42 million...

In early May 2026, Gibraltar Industries reported first-quarter sales of US$356.29 million, up from US$246.36 million a year earlier, but swung from a US$21.12 million profit to a US$67.47 million net loss largely tied to the OmniMax acquisition and discontinued Renewables operations. Despite this loss and margin pressure from commodity inflation and higher interest costs, management reaffirmed full-year 2026 guidance, signaling confidence in OmniMax integration benefits, improving...

Novanta recently announced that it will release its latest quarterly earnings results after the market close on Monday, with the market expecting year-on-year revenue growth of 8.6% following several quarters of revenue and operating income shortfalls versus analyst estimates. At the same time, CEO Matthijs Glastra sold 6,500 shares under a pre-arranged Rule 10b5-1 plan while retaining a significant indirect stake through a 2021 irrevocable trust, underscoring continued insider exposure...

In the first quarter of 2026, Repligen Corporation reported revenue of US$194.26 million and net income of US$8.33 million, both higher than a year earlier, and raised its full-year adjusted earnings guidance while slightly trimming its revenue outlook. These results reflected broad growth across key product lines, early benefits from a margin-focused restructuring program, and the impact of divesting the non-core Polymem filtration business. We’ll now examine how Repligen’s higher...

In the first quarter of 2026, Hecla Mining Company reported sales of US$411.43 million but booked a net loss of US$19.03 million, declared common and preferred dividends, and increased silver production to 3.9 million ounces, about 3% above the prior quarter. The combination of a debt-free balance sheet, record free cash flow from continuing operations, and a renewed focus on silver growth projects marks a significant shift in how Hecla funds expansion and rewards shareholders. With Hecla...

In late April 2026, CareDx, Inc. reported first-quarter 2026 revenue of US$117.7 million and net income of US$2.81 million, alongside basic and diluted earnings per share of US$0.05 from continuing operations, reversing a loss a year earlier. On the same day, CareDx raised its full-year 2026 revenue outlook to a range of US$447 million to US$465 million and filed an omnibus shelf registration, highlighting both improved operating performance and plans to retain flexibility in how it funds...

Assessing recent moves in EquipmentShare.com (EQPT) EquipmentShare.com (EQPT) has caught investor attention after a recent single day gain of 5.8%, extending an 18.5% rise over the past week, even as the stock remains down over the past 3 months and year to date. See our latest analysis for EquipmentShare.com. That sharp 1-day share price return of 5.83%, on top of a 7-day share price return of 18.48%, comes after a tougher stretch where the 90-day share price return declined 36.33% and the...

Expedia Group (EXPE) is back in focus after a packed Q1 2026 update, combining earnings, fresh guidance, a new US$5b buyback plan and a US$0.48 quarterly dividend declaration. See our latest analysis for Expedia Group. Despite a sharp 1 day share price drop of 9.02% and a year to date share price decline of 18.72%, Expedia Group still carries a 1 year total shareholder return of 38.63% and a 3 year total shareholder return of about 15x. This suggests that recent volatility sits against a much...

In April 2026, Park Hotels & Resorts reported first-quarter results showing sales of US$356 million and revenue of US$622 million, with net income of US$11 million compared with a net loss a year earlier. On the same day, the company slightly lowered its full-year 2026 earnings guidance, signaling more cautious expectations despite the return to profitability. We will now examine how Park’s improved quarterly profitability but trimmed full-year earnings outlook could influence the existing...

Centerspace (CSR) drew fresh attention after reporting Q1 2026 results that included lower sales, a wider net loss, and a reaffirmed outlook calling for flat to modest same-store revenue growth this year. See our latest analysis for Centerspace. The stock has had a mixed year, with a 30 day share price return of 5.84% and a 1 year total shareholder return of 16%. This suggests momentum has been building even as Q1 results and the ongoing review keep risks front of mind. If this kind of...

Earlier in May 2026, Everpure announced new Portworx capabilities for Red Hat OpenShift, including Plugin 2.2, Portworx Enterprise 3.6, and Portworx Backup 2.11, aimed at simplifying Kubernetes-native storage, backup, and disaster recovery for AI, container, and virtual machine workloads across hybrid and edge environments. This move deepens Everpure’s integration directly into the OpenShift console, making data management more accessible for enterprises standardizing on Kubernetes for...

In late April 2026, Unum Group reported first-quarter 2026 results showing higher revenue of US$3,355.2 million and net income of US$232 million, alongside completed share repurchases under two previously announced buyback programs totaling US$800 million and US$398.58 million. The combination of stronger earnings per share from continuing operations and meaningful reduction in shares outstanding underscores management’s focus on capital returns and earnings efficiency. With Unum’s recent...

Denali Therapeutics (DNLI) is back in focus after accelerated FDA approval of AVLAYAH, its first commercial product for neurologic Hunter syndrome in pediatric patients, with U.S. launch underway and initial payer discussions progressing. See our latest analysis for Denali Therapeutics. The AVLAYAH approval and pipeline updates come after a mixed share price pattern, with the stock up 20.59% year to date but longer term total shareholder returns still materially below earlier levels. This...

Ivanhoe Electric’s first-quarter 2026 results showed sales of US$858,000 and net income of US$41.74 million, a sharp turnaround from a net loss a year earlier, largely reflecting a very large gain from subsidiary Cordoba’s sale of the Alacrán copper-gold project. Alongside this profit swing, Ivanhoe Electric increased exploration spending at assets such as the Santa Cruz Copper Project and entered new copper-focused collaborations, including a partnership with SQM Chile, reshaping how...

In late April 2026, Sonoco Products Company filed a US$71.37 million shelf registration for 1,430,000 common shares tied to an ESOP-related offering. While the company recently reported strong earnings, the reliance on unusual items and flagged warning signs has raised questions about the quality and durability of its profit profile. We’ll now explore how the ESOP-related share issuance and questions over earnings quality intersect with Sonoco’s existing investment narrative. Uncover the...